Maverick Capital’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,177,090
Closed -$11.8M 235
2024
Q2
$11.8M Sell
1,177,090
-143,413
-11% -$1.46M 0.22% 53
2024
Q1
$15.2M Buy
1,320,503
+67,268
+5% +$571K 0.29% 58
2023
Q4
$9.14M Buy
1,253,235
+1,865
+0.1% +$14.7K 0.18% 55
2023
Q3
$11.4M Sell
1,251,370
-585,636
-32% -$7.02M 0.26% 45
2023
Q2
$22.4M Buy
1,837,006
+533,691
+41% +$5.95M 0.48% 39
2023
Q1
$16.2M Sell
1,303,315
-89,385
-6% -$1.64M 0.41% 36
2022
Q4
$26.8M Hold
1,392,700
0.63% 34
2022
Q3
$26.2M Buy
1,392,700
+21,458
+2% +$441K 0.59% 37
2022
Q2
$24.7M Sell
1,371,242
-29,413
-2% -$478K 0.61% 35
2022
Q1
$22.5M Sell
1,400,655
-229,031
-14% -$4.12M 0.39% 51
2021
Q4
$39.9M Buy
1,629,686
+27,667
+2% +$649K 0.45% 48
2021
Q3
$37.3M Buy
1,602,019
+733,333
+84% +$17.7M 0.38% 51
2021
Q2
$23.8M Buy
868,686
+844,562
+3,501% +$24.1M 0.22% 59
2021
Q1
$887K Buy
24,124
+13,843
+135% +$489K 0.01% 278
2020
Q4
$386K Buy
+10,281
New +$318K 0.01% 410

Other funds holding AHCO

Maverick Capital's AHCO Position: Q3 2024 in Review

Maverick Capital sold out of AdaptHealth (AHCO) in Q3 2024, closing a stake of 1,177,090 shares — an estimated $11.8M sold.

Maverick Capital first reported a position in AHCO in Q4 2020 and held it in 15 quarters. The position peaked at $39.9M in Q4 2021. 217 funds tracked by Wall St. Rank hold AHCO as of Q3 2024.

  • Maverick Capital reported no remaining AdaptHealth position as of Q3 2024 after selling out during the quarter.
  • Maverick Capital sold 1,177,090 AdaptHealth shares in Q3 2024, an estimated $11.8M.
  • Maverick Capital first reported a position in AdaptHealth in Q4 2020 and held it in 15 quarters.
  • Maverick Capital's AdaptHealth position peaked at $39.9M in Q4 2021.
  • 217 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2024.

Based on Maverick Capital's 13F filing for Q3 2024, filed 14 Nov 2024.